STAT Plus: Novartis employee claims she was fired for complaining about incorrect data
As Novartis (NVS) geared up to win approval for a new eye medication that was pegged to become a blockbuster, an employee tried to push the company to disclose incorrect safety data and claims she was fired for her trouble.
In a lawsuit filed earlier this week, Zuhal Butuner described how she suggested in March 2018 that Novartis either issue a press release or send letters to doctors about a “material error” in published safety data concerning Beovu, which was being developed to treat wet age-related macular degeneration. The medicine was approved last October by the Food and Drug Administration.